Mark Enyedy

Mark Enyedy

Director/Board Member bij ERGOMED

Vermogen: 188 090 $ op 29-02-2024

60 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Mark Joseph Enyedy is on the board of BioMarin Pharmaceutical, Inc., Biotechnology Innovation Organization, American Cancer Society New England Division, Inc. and Ergomed Plc.
In the past Mr. Enyedy held the position of President, Chief Executive Officer & Director at ImmunoGen, Inc., Chief Executive Officer & Director at Proteostasis Therapeutics, Inc., President-Transplant & Multiple Sclerosis at Genzyme Corp., Executive VP & Head-Corporate Development at Shire Plc and Associate of Palmer & Dodge LLP.
He received an undergraduate degree from Northeastern University and a graduate degree from Harvard Law School.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
27-12-2023 2 180 ( 0.00% ) 188 090 $ 29-02-2024

Actieve functies van Mark Enyedy

BedrijvenFunctieBegin
ERGOMED Director/Board Member 10-06-2021
BIOMARIN PHARMACEUTICAL INC. Director/Board Member 27-12-2023
American Cancer Society New England Division, Inc. Director/Board Member -
Director/Board Member -
Alle actieve functies van Mark Enyedy

Eerdere bekende functies van Mark Enyedy

BedrijvenFunctieEinde
IMMUNOGEN, INC. Chief Executive Officer 12-02-2024
LOGICBIO THERAPEUTICS, INC. Director/Board Member 16-11-2022
AKEBIA THERAPEUTICS, INC. Director/Board Member 02-06-2021
KERYX BIOPHARMACEUTICALS Director/Board Member 12-12-2018
FATE THERAPEUTICS, INC. Director/Board Member 02-05-2018
Ervaring van Mark Enyedy in detail bekijken

Opleiding van Mark Enyedy

Northeastern University Undergraduate Degree
Harvard Law School Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Enyedy in detail bekijken

Connecties

100 +

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven5
IMMUNOGEN, INC.

Health Technology

BIOMARIN PHARMACEUTICAL INC.

Health Technology

AKEBIA THERAPEUTICS, INC.

Health Technology

FATE THERAPEUTICS, INC.

Health Technology

ERGOMED

Commercial Services

Bedrijven in privébezit8

Health Technology

Health Technology

Commercial Services

Health Technology

Palmer & Dodge LLP

Commercial Services

Health Technology

American Cancer Society New England Division, Inc.

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Enyedy